CERVICAL ADENOCARCINOMA
Clinical trials for CERVICAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new radioactive drug that seeks out a protein called Nectin-4 on cancer cells. It is for people with advanced solid tumors (like bladder, breast, lung, or cervical cancer) that have not responded to prior treatments. The main goals are to find a saf…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New hope for rare cervical cancer: triple-drug combo enters trial
Disease control Recruiting nowThis study tests a new combination of three drugs (IN10018, nab-paclitaxel, and cadonilimab) for women with a rare, aggressive cervical cancer that has spread or returned. The goal is to see if the treatment can shrink tumors and control the disease. About 25 adult women who have…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Shorter radiation may ease cervical cancer treatment in uganda
Disease control Recruiting nowThis study tests whether a shorter, higher-dose radiation schedule (hypofractionated) is as safe and effective as the standard longer schedule for women with locally advanced cervical cancer. About 278 women in Uganda will receive either the shorter or standard radiation, plus ch…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Uganda Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New drug targets tumors directly in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called AVA6103 in about 144 people with advanced solid tumors (like pancreatic, stomach, or lung cancer) that have not responded to standard treatments. The drug is designed to activate only inside tumors to kill cancer cells while limiting…
Matched conditions: CERVICAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated May 06, 2026 16:03 UTC